Home
IGC
IGC News

Latest IGC Pharma Inc. (IGC) News on December 29, 2024

ACCESSWIRE

9 days ago

IGC Pharma Announces Participation in BioPartnering at JPM Alongside the J.P. Morgan 43rd Annual Healthcare Conference 2025

ACCESSWIRE

a month ago

IGC Pharma Advances IGC-AD1 as a Potential Alzheimer's Therapy Addressing Cognitive Impairment and Underlying Disease Pathology

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment

Business Wire

a month ago

IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline

ACCESSWIRE

a month ago

IGC Pharma Reports Second Quarter Fiscal 2025 Results, Showcasing Progress in Its Alzheimer’s Pipeline

ACCESSWIRE

2 months ago

IGC Pharma Announces Publication of IMS Spotlight Interview Highlighting Strategic Expansion in Alzheimer’s and Weight Loss Therapies

ACCESSWIRE

2 months ago

IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge

ACCESSWIRE

3 months ago

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment

Business Wire

3 months ago

IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer's Treatment

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease

Business Wire

4 months ago

IGC Pharma Advances IGC-AD1 Toward Clinical Trials as a Potential anti-Amyloid Plaque Treatment for Alzheimer's Disease

IGC Announces Results of its 2024 Annual Stockholders Meeting

Business Wire

4 months ago

IGC Announces Results of its 2024 Annual Stockholders Meeting

IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease

Business Wire

4 months ago

IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease

IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist

Business Wire

4 months ago

IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist

IGC Pharma Reports First Quarter Fiscal 2025 Results

Business Wire

5 months ago

IGC Pharma Reports First Quarter Fiscal 2025 Results

IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target

Business Wire

5 months ago

IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target

Business Wire

6 months ago

Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile

IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease

Business Wire

6 months ago

IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease

IGC Reports Financial Results for Fiscal Year Ended March 31, 2024

Business Wire

6 months ago

IGC Reports Financial Results for Fiscal Year Ended March 31, 2024

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

Business Wire

6 months ago

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

Business Wire

7 months ago

IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1

Business Wire

7 months ago

IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1

IGC Pharma to Attend BIO International Convention 2024

Business Wire

7 months ago

IGC Pharma to Attend BIO International Convention 2024

IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two

Business Wire

8 months ago

IGC-AD1’s Interim Phase 2 Data Show a Reduction in Alzheimer’s Agitation at Week Two

IGC Pharma Adds Advisor in Artificial Intelligence

Business Wire

9 months ago

IGC Pharma Adds Advisor in Artificial Intelligence

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock

Business Wire

9 months ago

IGC Pharma Announces $3 Million Unregistered Private Placement of its Common Stock

IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation

Business Wire

9 months ago

IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation

IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024

Business Wire

9 months ago

IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline

Business Wire

10 months ago

IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline

Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model

Business Wire

10 months ago

Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model

IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target

Business Wire

10 months ago

IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target

IGC Pharma Reports Third Quarter Fiscal 2024 Results

Business Wire

10 months ago

IGC Pharma Reports Third Quarter Fiscal 2024 Results

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model

Business Wire

a year ago

IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model

Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer

GlobeNewswire

a year ago

Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer

IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

Business Wire

a year ago

IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation

Simply Wall St.

a year ago

SPAR Group (NASDAQ:SGRP) Is Very Good At Capital Allocation

Jewelry Looking Grimy? Here’s How to Clean It at Home

The Wall Street Journal

a year ago

Jewelry Looking Grimy? Here’s How to Clean It at Home

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial

Business Wire

a year ago

IGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing Phase 2b Alzheimer’s Trial

Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings

InvestorPlace

a year ago

Contrarian Kings: 3 Unloved Stocks That Could Be the Next Market Darlings

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation

PR Newswire

a year ago

IceCure Medical's ProSense® Featured at Indian Society of Vascular and Interventional Radiology Conference: Key Opinion Leaders Highlight Benefits of Cryoablation

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

GuruFocus.com

a year ago

Seth Klarman's Firm Exits Atara Biotherapeutics Inc Holding

Pathward Financial, Inc. to Announce First Quarter 2024 Earnings and Host Conference Call on January 24, 2024

Business Wire

a year ago

Pathward Financial, Inc. to Announce First Quarter 2024 Earnings and Host Conference Call on January 24, 2024

Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

GlobeNewswire

a year ago

Alarum Estimates Record Revenue and All Time High Operating Cashflow for the Fourth Quarter of 2023

CardRatings Unveils Its ‘Best Credit Cards of 2024’ List and Annual Cardholder Survey Results

Business Wire

a year ago

CardRatings Unveils Its ‘Best Credit Cards of 2024’ List and Annual Cardholder Survey Results

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Business Wire

a year ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code

Business Wire

a year ago

American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code

Milestone Pharma (MIST) Down on Regulatory Update for Etripamil

Zacks

a year ago

Milestone Pharma (MIST) Down on Regulatory Update for Etripamil

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

PR Newswire

a year ago

MicroAlgo Inc. Developed QSDLT to Provide a More Secure Foundation for Bitcoin and Other Cryptocurrency Systems

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

GlobeNewswire

a year ago

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Parke Bancorp (NASDAQ:PKBK) Has Announced A Dividend Of $0.18

Simply Wall St.

a year ago

Parke Bancorp (NASDAQ:PKBK) Has Announced A Dividend Of $0.18

Ark Restaurants Corp. (NASDAQ:ARKR) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Ark Restaurants Corp. (NASDAQ:ARKR) Q4 2023 Earnings Call Transcript

Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s

Business Wire

a year ago

Patent Granted to IGC Pharma for Groundbreaking Drug Formulation to Treat Agitation in Alzheimer’s

Finance of America Receives Continued Listing Standard Notice from the NYSE

Business Wire

a year ago

Finance of America Receives Continued Listing Standard Notice from the NYSE

Positive Signs As Multiple Insiders Buy Chimerix Stock

Simply Wall St.

a year ago

Positive Signs As Multiple Insiders Buy Chimerix Stock

IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024

Business Wire

a year ago

IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024

Navitas “Electrify Our World™” at CES 2024

GlobeNewswire

a year ago

Navitas “Electrify Our World™” at CES 2024

IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials

Business Wire

a year ago

IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

GlobeNewswire

a year ago

Athira Pharma Announces Upcoming Presentation at Motor Neurone Disease Association’s 34ᵗʰ International Symposium on ALS/MND

ClearSign Technologies (NASDAQ:CLIR) delivers shareholders notable 98% return over 1 year, surging 59% in the last week alone

Simply Wall St.

a year ago

ClearSign Technologies (NASDAQ:CLIR) delivers shareholders notable 98% return over 1 year, surging 59% in the last week alone

IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives

Business Wire

a year ago

IGC Pharma Announces Master Agreement with Leading South American University to Advance AI Initiatives

Finance of America Chooses Spera Security to Bolster its Identity Security

GlobeNewswire

a year ago

Finance of America Chooses Spera Security to Bolster its Identity Security

Allot Communications (ALLT) Reports Q3 Loss, Tops Revenue Estimates

Zacks

a year ago

Allot Communications (ALLT) Reports Q3 Loss, Tops Revenue Estimates

OrbiMed Advisors LLC Reduces Stake in Kinnate Biopharma Inc

GuruFocus.com

a year ago

OrbiMed Advisors LLC Reduces Stake in Kinnate Biopharma Inc

Business Wire

a year ago

BlackRock Enhanced Government Fund, Inc. Announces Expiration of Annual Repurchase Offer

IGC Pharma Reports Second Quarter Fiscal 2024 Results

Business Wire

a year ago

IGC Pharma Reports Second Quarter Fiscal 2024 Results

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Spruce Power Holding Corporation (NYSE:SPRU) Q3 2023 Earnings Call Transcript

WideOpenWest, Inc. (NYSE:WOW) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

WideOpenWest, Inc. (NYSE:WOW) Q3 2023 Earnings Call Transcript

Analysts Just Made A Major Revision To Their Synchronoss Technologies, Inc. (NASDAQ:SNCR) Revenue Forecasts

Simply Wall St.

a year ago

Analysts Just Made A Major Revision To Their Synchronoss Technologies, Inc. (NASDAQ:SNCR) Revenue Forecasts

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million

GuruFocus.com

a year ago

RumbleON Inc (RMBL) Reports Q3 2023 Financial Results: Net Loss of $16.5 Million

Allied Gaming & Entertainment to Report Third Quarter 2023 Results on Thursday, November 9th

Business Wire

a year ago

Allied Gaming & Entertainment to Report Third Quarter 2023 Results on Thursday, November 9th

This Broker Just Slashed Their ARB IOT Group Limited (NASDAQ:ARBB) Earnings Forecasts

Simply Wall St.

a year ago

This Broker Just Slashed Their ARB IOT Group Limited (NASDAQ:ARBB) Earnings Forecasts

Aware Inc (AWRE) Q3 2023 Earnings: Revenue Soars by 112% to $6.4 Million

GuruFocus.com

a year ago

Aware Inc (AWRE) Q3 2023 Earnings: Revenue Soars by 112% to $6.4 Million

aTyr Pharma to Present at November Investor Conferences

GlobeNewswire

a year ago

aTyr Pharma to Present at November Investor Conferences

Share on Social Networks: